Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

31. Oktober 2018 11:00 ET | Quelle: NeuroMetrix, Inc.

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

WALTHAM, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,112,040 titled...
18. Oktober 2018 11:00 ET | Quelle: NeuroMetrix, Inc.

NeuroMetrix Reports DPNCheck to be Featured at Upcoming 33rd Japan Society of Diabetic Complications Annual Meeting in Tokyo

WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), reported that DPNCheck®, its rapid, point-of-care test for diabetic peripheral neuropathy (DPN), will be featured...
17. Oktober 2018 07:00 ET | Quelle: NeuroMetrix, Inc.

NeuroMetrix Reports Q3 2018 Financial Results

WALTHAM, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended September 30, 2018. The Company...
10. Oktober 2018 11:00 ET | Quelle: NeuroMetrix, Inc.

NeuroMetrix, Inc. Announces Date for 2018 Third Quarter Financial Results Conference Call

WALTHAM, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2018 third quarter financial results before the opening of the market...
02. Oktober 2018 11:00 ET | Quelle: NeuroMetrix, Inc.

NeuroMetrix Reports Publication of New Clinical Study on Quell Wearable Pain Relief Technology

WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported publication of a clinical study of Quell® wearable pain relief in the Journal of Pain and Relief. ...
25. September 2018 10:00 ET | Quelle: NeuroMetrix, Inc.

NeuroMetrix To Present Quell 2.0 at DTxDM East: The Digital Therapeutics and Digital Medicine Event in Boston

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today announced that it will showcase its latest product innovation, Quell® 2.0 Wearable Pain Relief Technology™,...
20. September 2018 13:00 ET | Quelle: NeuroMetrix, Inc.

NeuroMetrix Reports Discussion of Quell Wearable Pain Relief Technology on the Fox Business Network

WALTHAM, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), reported that its President and CEO, Dr. Shai N. Gozani, yesterday participated in a discussion of the opioid...
29. August 2018 13:00 ET | Quelle: NeuroMetrix, Inc.

NeuroMetrix to Exhibit and Sponsor Symposium on the Early Diagnosis of Diabetic Peripheral Neuropathy at the Annual Meeting of NEURODIAB

WALTHAM, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it will be both exhibiting and sponsoring a diabetic neuropathy symposium at the 28th Annual...
28. August 2018 11:00 ET | Quelle: NeuroMetrix, Inc.

NeuroMetrix Reports Presentation of Clinical and Scientific Data on Quell Wearable Pain Relief Technology at PAINWeek 2018 National Conference

WALTHAM, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported that it will present three scientific posters at the upcoming PAINWeek 2018 National Pain Conference...
27. August 2018 13:30 ET | Quelle: NeuroMetrix, Inc.

NeuroMetrix to Present at H.C.Wainwright & Co 20th Annual Global Investment Conference in New York City

WALTHAM, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) reported that the time previously announced for its presentation at the H.C.Wainwright 20th Annual Global...

Vorherige Seite